Sirona Biochem (OTCPK: SRBCF), a biopharmaceutical company focused on discovering novel cosmetic and pharmaceutical compounds, announced the grant of a patent for TFC-1067, its lead skin lightening compound. It uses its proprietary fluorination chemistry, to create unique and superior compounds, which are hydroquinone free and...
Severe combined immunodeficiency (SCID) or “Bubble Boy Syndrome” is a rare genetic disorder caused by gene mutations that inhibit the functioning of immune cells. Children afflicted with this condition are healthy in appearance but are susceptible to severe infections, even a common cold can prove...
Standing Tall ReWalk Robotics (NASDAQ: RWLK) recently received an approval for its ReStore exoskeleton system, indicated for rehabilitation of stroke victims, from the FDA. The company also manufactures ReWalk robotic exoskeleton, the first to receive FDA approval for personal and rehabilitation use in the United States. It...
Human Immunodeficiency Virus (HIV) compromises the body’s immunity by attacking CD4 cells (a type of T cell), exposing it to a host of infections and diseases and ultimately leading to the development of AIDS. According to data provided by Centres for Disease Control and Prevention,...
Obalon Therapeutics (NASDAQ: OBLN), the manufacturer of the first and only FDA-approved swallowable, gas-filled intragastric balloon system to combat obesity, has announced the grant of U.S patent no. 10,264,995 entitled “SYSTEMS AND METHODS FOR LOCATING AND/OR CHARACTERIZING INTRAGASTRIC DEVICES. This will help expand the company’s...
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinical trials of GEN-009, its neoantigen vaccine candidate. There has been a stream of positive news from the company’s stables off late, including news of Journal of Clinical Oncology® selecting...
Imagination Park Technologies Inc. (CSE: IP) (OTCQB: IPNFF), an augmented reality (AR) platform, announced that it has acquired XenoHolographic. The transaction involved the transfer of 6,915,600 million shares to Interknowlogy, in exchange for 100% of XenoHolographic, including intellectual property and patents. XenoHolograpic is a developer of...
Systemic lupus erythematosus (SLE) is an autoimmune disease that causes the body’s immune system to attack healthy tissue causing inflammation, photosensitivity, oral ulcers, pleuritis, joint pain, arthritis, fever and a butterfly rash. In the long-run it can affect the kidneys, brain and heart as well....
Shares of Maxar Technologies (NYSE: MAXR) rose by almost 28% on May 23, before plunging 10%, summing up what turned out to be a rollercoaster week for its stock. The jump in the stock was due to the news that it was chosen to build and...
Cara Therapeutics (NASDAQ: CARA) recently posted its first quarter, 2019 results. The company reported a net loss of $22.0 million, or $0.56 per basic and diluted share compared to a net loss of $16.8 million, or $0.51 per basic and diluted share, for the first...
